109 related articles for article (PubMed ID: 19736520)
21. TAL1 as a master oncogenic transcription factor in T-cell acute lymphoblastic leukemia.
Sanda T; Leong WZ
Exp Hematol; 2017 Sep; 53():7-15. PubMed ID: 28652130
[TBL] [Abstract][Full Text] [Related]
22. Site- and allele-specific polycomb dysregulation in T-cell leukaemia.
Navarro JM; Touzart A; Pradel LC; Loosveld M; Koubi M; Fenouil R; Le Noir S; Maqbool MA; Morgado E; Gregoire C; Jaeger S; Mamessier E; Pignon C; Hacein-Bey-Abina S; Malissen B; Gut M; Gut IG; Dombret H; Macintyre EA; Howe SJ; Gaspar HB; Thrasher AJ; Ifrah N; Payet-Bornet D; Duprez E; Andrau JC; Asnafi V; Nadel B
Nat Commun; 2015 Jan; 6():6094. PubMed ID: 25615415
[TBL] [Abstract][Full Text] [Related]
23. Assembly of the oncogenic DNA-binding complex LMO2-Ldb1-TAL1-E12.
Ryan DP; Duncan JL; Lee C; Kuchel PW; Matthews JM
Proteins; 2008 Mar; 70(4):1461-74. PubMed ID: 17910069
[TBL] [Abstract][Full Text] [Related]
24. Cross talk among Notch3, pre-TCR, and Tal1 in T-cell development and leukemogenesis.
Talora C; Cialfi S; Oliviero C; Palermo R; Pascucci M; Frati L; Vacca A; Gulino A; Screpanti I
Blood; 2006 Apr; 107(8):3313-20. PubMed ID: 16368887
[TBL] [Abstract][Full Text] [Related]
25. Lmo2 and Scl/Tal1 convert non-axial mesoderm into haemangioblasts which differentiate into endothelial cells in the absence of Gata1.
Gering M; Yamada Y; Rabbitts TH; Patient RK
Development; 2003 Dec; 130(25):6187-99. PubMed ID: 14602685
[TBL] [Abstract][Full Text] [Related]
26. Cryosectioning the intestinal crypt-villus axis: an ex vivo method to study the dynamics of epigenetic modifications from stem cells to differentiated cells.
Vincent A; Kazmierczak C; Duchêne B; Jonckheere N; Leteurtre E; Van Seuningen I
Stem Cell Res; 2015 Jan; 14(1):105-13. PubMed ID: 25590428
[TBL] [Abstract][Full Text] [Related]
27. Isoforms of the TAL1 transcription factor have different roles in hematopoiesis and cell growth.
Sharma A; Mistriel-Zerbib S; Najar RA; Engal E; Bentata M; Taqatqa N; Dahan S; Cohen K; Jaffe-Herman S; Geminder O; Baker M; Nevo Y; Plaschkes I; Kay G; Drier Y; Berger M; Salton M
PLoS Biol; 2023 Jun; 21(6):e3002175. PubMed ID: 37379322
[TBL] [Abstract][Full Text] [Related]
28. Lyl1 interacts with CREB1 and alters expression of CREB1 target genes.
San-Marina S; Han Y; Suarez Saiz F; Trus MR; Minden MD
Biochim Biophys Acta; 2008 Mar; 1783(3):503-17. PubMed ID: 18160048
[TBL] [Abstract][Full Text] [Related]
29. Tal1 regulates osteoclast differentiation through suppression of the master regulator of cell fusion DC-STAMP.
Courtial N; Smink JJ; Kuvardina ON; Leutz A; Göthert JR; Lausen J
FASEB J; 2012 Feb; 26(2):523-32. PubMed ID: 21990371
[TBL] [Abstract][Full Text] [Related]
30. Forced FOG1 expression in erythroleukemia cells: Induction of erythroid genes and repression of myelo-lymphoid transcription factor PU.1.
Fujiwara T; Sasaki K; Saito K; Hatta S; Ichikawa S; Kobayashi M; Okitsu Y; Fukuhara N; Onishi Y; Harigae H
Biochem Biophys Res Commun; 2017 Apr; 485(2):380-387. PubMed ID: 28216155
[TBL] [Abstract][Full Text] [Related]
31. Adult hematopoiesis is regulated by TIF1γ, a repressor of TAL1 and PU.1 transcriptional activity.
Kusy S; Gault N; Ferri F; Lewandowski D; Barroca V; Jaracz-Ros A; Losson R; Romeo PH
Cell Stem Cell; 2011 Apr; 8(4):412-25. PubMed ID: 21474105
[TBL] [Abstract][Full Text] [Related]
32. Impairment of granulo-monocytic development of human common myeloid progenitors but not of granulo-monocytic progenitors by decreasing stem cell leukemia/T-cell acute leukemia 1 expression.
Brunet de la Grange P; Zink E; Armstrong F; Rouyez MC; Pflumio F
Stem Cells; 2008 Jun; 26(6):1658-62. PubMed ID: 18436863
[TBL] [Abstract][Full Text] [Related]
33. TAL1/SCL is downregulated upon histone deacetylase inhibition in T-cell acute lymphoblastic leukemia cells.
Cardoso BA; de Almeida SF; Laranjeira AB; Carmo-Fonseca M; Yunes JA; Coffer PJ; Barata JT
Leukemia; 2011 Oct; 25(10):1578-86. PubMed ID: 21647153
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms of epigenetic and cell-type specific regulation of Hey target genes in ES cells and cardiomyocytes.
Weber D; Heisig J; Kneitz S; Wolf E; Eilers M; Gessler M
J Mol Cell Cardiol; 2015 Feb; 79():79-88. PubMed ID: 25446183
[TBL] [Abstract][Full Text] [Related]
35. Scl binds to primed enhancers in mesoderm to regulate hematopoietic and cardiac fate divergence.
Org T; Duan D; Ferrari R; Montel-Hagen A; Van Handel B; Kerényi MA; Sasidharan R; Rubbi L; Fujiwara Y; Pellegrini M; Orkin SH; Kurdistani SK; Mikkola HK
EMBO J; 2015 Mar; 34(6):759-77. PubMed ID: 25564442
[TBL] [Abstract][Full Text] [Related]
36. Genomic approaches uncover increasing complexities in the regulatory landscape at the human SCL (TAL1) locus.
Dhami P; Bruce AW; Jim JH; Dillon SC; Hall A; Cooper JL; Bonhoure N; Chiang K; Ellis PD; Langford C; Andrews RM; Vetrie D
PLoS One; 2010 Feb; 5(2):e9059. PubMed ID: 20140202
[TBL] [Abstract][Full Text] [Related]
37. Analysis of chromatin-state plasticity identifies cell-type-specific regulators of H3K27me3 patterns.
Pinello L; Xu J; Orkin SH; Yuan GC
Proc Natl Acad Sci U S A; 2014 Jan; 111(3):E344-53. PubMed ID: 24395799
[TBL] [Abstract][Full Text] [Related]
38. p300 functions as a transcriptional coactivator for the TAL1/SCL oncoprotein.
Huang S; Qiu Y; Stein RW; Brandt SJ
Oncogene; 1999 Sep; 18(35):4958-67. PubMed ID: 10490830
[TBL] [Abstract][Full Text] [Related]
39. p16Ink4a or p19Arf loss contributes to Tal1-induced leukemogenesis in mice.
Shank-Calvo JA; Draheim K; Bhasin M; Kelliher MA
Oncogene; 2006 May; 25(21):3023-31. PubMed ID: 16407836
[TBL] [Abstract][Full Text] [Related]
40. Histone-modifying enzymes: their role in the pathogenesis of acute leukemia and their therapeutic potential.
Vu LP; Luciani L; Nimer SD
Int J Hematol; 2013 Feb; 97(2):198-209. PubMed ID: 23288492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
